These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
681 related items for PubMed ID: 18634509
21. Genetically modified rabies virus ERA strain is safe and induces long-lasting protective immune response in dogs after oral vaccination. Shuai L, Feng N, Wang X, Ge J, Wen Z, Chen W, Qin L, Xia X, Bu Z. Antiviral Res; 2015 Sep; 121():9-15. PubMed ID: 26093157 [Abstract] [Full Text] [Related]
26. DNA-based immunisation against rabies and rabies-related viruses: towards multivalent vaccines. Perrin P, Jacob Y, Desmézières E, Tordo N. Dev Biol (Basel); 2000 Jul; 104():151-7. PubMed ID: 11713814 [Abstract] [Full Text] [Related]
27. [Construction and identification of recombinant canine adenovirus type 2 expressing exogenous rabies glycoprotein (Rgp)]. Zhao ZP, Xia XZ, Hu RL, Xie ZJ, Yan F, Huang G, Yang ST. Wei Sheng Wu Xue Bao; 2007 Apr; 47(2):335-9. PubMed ID: 17552245 [Abstract] [Full Text] [Related]
28. Induction of immune responses and protection in mice against rabies using a self-replicating RNA vaccine encoding rabies virus glycoprotein. Saxena S, Sonwane AA, Dahiya SS, Patel CL, Saini M, Rai A, Gupta PK. Vet Microbiol; 2009 Apr 14; 136(1-2):36-44. PubMed ID: 19081687 [Abstract] [Full Text] [Related]
29. Field trials of a very potent rabies DNA vaccine which induced long lasting virus neutralizing antibodies and protection in dogs in experimental conditions. Bahloul C, Taieb D, Diouani MF, Ahmed SB, Chtourou Y, B'chir BI, Kharmachi H, Dellagi K. Vaccine; 2006 Feb 20; 24(8):1063-72. PubMed ID: 16213633 [Abstract] [Full Text] [Related]
32. A recombinant pseudorabies virus expressing rabies virus glycoprotein: safety and immunogenicity in dogs. Yuan Z, Zhang S, Liu Y, Zhang F, Fooks AR, Li Q, Hu R. Vaccine; 2008 Mar 04; 26(10):1314-21. PubMed ID: 18262313 [Abstract] [Full Text] [Related]
35. Development of rabies DNA vaccine using a recombinant plasmid. Rai N, Kaushik P, Rai A. Acta Virol; 2005 Mar 04; 49(3):207-10. PubMed ID: 16178518 [Abstract] [Full Text] [Related]
36. A DNA vaccine that encodes rabies virus glycoprotein lacking transmembrane domain enhances antibody response but not protection. Gupta PK, Sharma S, Walunj SS, Patil AA, Rai A, Saini M. Acta Virol; 2006 Mar 04; 50(2):87-92. PubMed ID: 16808325 [Abstract] [Full Text] [Related]
38. Generation and evaluation of a recombinant modified vaccinia virus Ankara vaccine for rabies. Weyer J, Rupprecht CE, Mans J, Viljoen GJ, Nel LH. Vaccine; 2007 May 22; 25(21):4213-22. PubMed ID: 17434244 [Abstract] [Full Text] [Related]
39. Comparison of systemic and mucosal delivery of 2 canarypox virus vaccines expressing either HIV-1 genes or the gene for rabies virus G protein. Wright PF, Mestecky J, McElrath MJ, Keefer MC, Gorse GJ, Goepfert PA, Moldoveanu Z, Schwartz D, Spearman PW, El Habib R, Spring MD, Zhu Y, Smith C, Flores J, Weinhold KJ, National Institutes of Allergy and Infectious Diseases AIDS Vaccine Evaluation Group. J Infect Dis; 2004 Apr 01; 189(7):1221-31. PubMed ID: 15031791 [Abstract] [Full Text] [Related]
40. Rabies vaccines: duration-of-immunity study in dogs. Sikes RK, Peacock GV, Acha P, Arko RJ, Dierks R. J Am Vet Med Assoc; 1971 Dec 01; 159(11):1491-9. PubMed ID: 5153870 [No Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]